Alzamend Neuro, Inc. (ALZN)
NASDAQ: ALZN · Real-Time Price · USD
1.700
+0.063 (3.85%)
At close: Sep 2, 2026, 4:00 PM EDT
1.680
-0.020 (-1.15%)
After-hours: Sep 2, 2026, 7:30 PM EDT
Alzamend Neuro Income Statement
Financials in millions USD. Fiscal year is May - April.
Millions USD. Fiscal year is May - Apr.
Fiscal Quarter | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Period Ending | Apr '26 Apr 30, 2026 | Jan '26 Jan 31, 2026 | Oct '25 Oct 31, 2025 | Jul '25 Jul 31, 2025 | Apr '25 Apr 30, 2025 | Jan '25 Jan 31, 2025 | Oct '24 Oct 31, 2024 | Jul '24 Jul 31, 2024 | Apr '24 Apr 30, 2024 | Jan '24 Jan 31, 2024 | Oct '23 Oct 31, 2023 | Jul '23 Jul 31, 2023 | Apr '23 Apr 30, 2023 | Jan '23 Jan 31, 2023 | Oct '22 Oct 31, 2022 | Jul '22 Jul 31, 2022 | Apr '22 Apr 30, 2022 | Jan '22 Jan 31, 2022 | Oct '21 Oct 31, 2021 | Jul '21 Jul 31, 2021 |
Selling, General & Admin | 5.14 | 3.39 | 3.06 | 3.29 | 3.08 | 3.06 | 3.22 | 3.08 | 3.48 | 4.47 | 6.26 | 6.92 | 7.42 | 7.98 | 7.13 | 7.39 | 7.12 | 5.83 | 5.03 | 4.02 |
Research & Development | 3.63 | 3.65 | 2.81 | 2.95 | 1.41 | 1.15 | 2.61 | 4.3 | 6.46 | 7.92 | 8.9 | 8.44 | 7.45 | 7.46 | 5.44 | 5.66 | 5.2 | 3.83 | 3.19 | 1.92 |
Operating Expenses | 8.77 | 7.03 | 5.87 | 6.23 | 4.5 | 4.21 | 5.83 | 7.37 | 9.94 | 12.39 | 15.16 | 15.36 | 14.87 | 15.44 | 12.57 | 13.05 | 12.32 | 9.67 | 8.23 | 5.94 |
Operating Income | -8.77 | -7.03 | -5.87 | -6.23 | -4.5 | -4.21 | -5.83 | -7.37 | -9.94 | -12.39 | -15.16 | -15.36 | -14.87 | -15.44 | -12.57 | -13.05 | -12.32 | -9.67 | -8.23 | -5.94 |
Interest Expense | -0.01 | -0.01 | -0.01 | -0.01 | -0.02 | -0.02 | -0.02 | -0.02 | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 | -0.02 | -0.03 | -0.05 | -0.08 | -0.13 | -0.17 |
Interest & Investment Income | 0 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
EBT Excluding Unusual Items | -8.77 | -7.04 | -5.88 | -6.24 | -4.51 | -4.23 | -5.85 | -7.39 | -9.95 | -12.4 | -15.16 | -15.37 | -14.88 | -15.45 | -12.59 | -13.08 | -12.37 | -9.75 | -8.36 | -6.11 |
Other Unusual Items | - | - | - | - | - | - | - | - | - | - | - | - | - | 0 | 0 | 0 | 0 | - | 0.06 | 0.06 |
Pretax Income | -8.77 | -7.04 | -5.88 | -6.24 | -4.51 | -4.23 | -5.85 | -7.39 | -9.95 | -12.4 | -15.16 | -15.37 | -14.88 | -15.44 | -12.59 | -13.08 | -12.36 | -9.75 | -8.3 | -6.05 |
Net Income | -8.77 | -7.04 | -5.88 | -6.24 | -4.51 | -4.23 | -5.85 | -7.39 | -9.95 | -12.4 | -15.16 | -15.37 | -14.88 | -15.44 | -12.59 | -13.08 | -12.36 | -9.75 | -8.3 | -6.05 |
Preferred Dividends & Other Adjustments | - | 0.5 | 0.59 | 0.59 | 0.59 | 0.09 | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Net Income to Common | -8.77 | -7.54 | -6.47 | -6.83 | -5.11 | -4.31 | -5.85 | -7.39 | -9.95 | -12.4 | -15.16 | -15.37 | -14.88 | -15.44 | -12.59 | -13.08 | -12.36 | -9.75 | -8.3 | -6.05 |
Net Income Growth (YoY) | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Shares Outstanding (Basic) | 3 | 3 | 2 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Shares Outstanding (Diluted) | 3 | 3 | 2 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Shares Change (YoY) | 640.27% | 765.27% | 985.74% | 1121.34% | 499.67% | 293.71% | 118.23% | 8.09% | 4.07% | 4.79% | 4.52% | 5.89% | 9.45% | 11.38% | 16.34% | 21.90% | 22.64% | 18.56% | 12.05% | 5.79% |
EPS (Basic) | -2.63 | -2.99 | -3.76 | -7.15 | -11.32 | -14.81 | -36.93 | -94.47 | -132.33 | -167.64 | -208.90 | -212.24 | -205.97 | -218.73 | -181.26 | -191.26 | -187.31 | -153.82 | -138.96 | -107.84 |
EPS (Diluted) | -2.63 | -2.99 | -3.76 | -7.15 | -11.32 | -14.81 | -36.93 | -94.47 | -132.33 | -167.64 | -208.90 | -212.24 | -205.97 | -218.73 | -181.26 | -191.26 | -187.31 | -153.82 | -138.96 | -107.84 |
EPS Growth (YoY) | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Additional Metrics
Fiscal Quarter | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Period Ending | Apr '26 Apr 30, 2026 | Jan '26 Jan 31, 2026 | Oct '25 Oct 31, 2025 | Jul '25 Jul 31, 2025 | Apr '25 Apr 30, 2025 | Jan '25 Jan 31, 2025 | Oct '24 Oct 31, 2024 | Jul '24 Jul 31, 2024 | Apr '24 Apr 30, 2024 | Jan '24 Jan 31, 2024 | Oct '23 Oct 31, 2023 | Jul '23 Jul 31, 2023 | Apr '23 Apr 30, 2023 | Jan '23 Jan 31, 2023 | Oct '22 Oct 31, 2022 | Jul '22 Jul 31, 2022 | Apr '22 Apr 30, 2022 | Jan '22 Jan 31, 2022 | Oct '21 Oct 31, 2021 | Jul '21 Jul 31, 2021 |
Free Cash Flow | -8.07 | -6.17 | -5.86 | -8.09 | -6.87 | -7.4 | -8 | -6.12 | -8.42 | -9.23 | -9 | -9.83 | -8.92 | -8.36 | -8.33 | -8.03 | -6.72 | -6.31 | -5.33 | -3.73 |
Free Cash Flow Per Share | -2.42 | -2.45 | -3.40 | -8.46 | -15.24 | -25.39 | -50.52 | -78.16 | -111.97 | -124.70 | -123.99 | -135.77 | -123.53 | -118.37 | -119.97 | -117.49 | -101.83 | -99.55 | -89.33 | -66.48 |
EBITDA | -8.66 | -6.94 | -5.79 | -6.17 | -4.45 | -4.16 | -5.78 | -7.32 | -9.89 | -12.35 | -15.12 | -15.33 | -14.85 | - | - | - | -12.32 | - | - | - |
D&A For EBITDA | 0.11 | 0.1 | 0.08 | 0.07 | 0.05 | 0.05 | 0.05 | 0.05 | 0.05 | 0.04 | 0.04 | 0.03 | 0.02 | - | - | - | 0 | - | - | - |
EBIT | -8.77 | -7.03 | -5.87 | -6.23 | -4.5 | -4.21 | -5.83 | -7.37 | -9.94 | -12.39 | -15.16 | -15.36 | -14.87 | -15.44 | -12.57 | -13.05 | -12.32 | -9.67 | -8.23 | -5.94 |